BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1111 related articles for article (PubMed ID: 18400254)

  • 21. Comparison of DNA ploidy, histologic, and immunohistochemical findings with clinical outcome in inflammatory myofibroblastic tumors.
    Hussong JW; Brown M; Perkins SL; Dehner LP; Coffin CM
    Mod Pathol; 1999 Mar; 12(3):279-86. PubMed ID: 10102613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-beta1 drives partial myofibroblastic differentiation in chondromyxoid fibroma of bone.
    Romeo S; Eyden B; Prins FA; Briaire-de Bruijn IH; Taminiau AH; Hogendoorn PC
    J Pathol; 2006 Jan; 208(1):26-34. PubMed ID: 16278817
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical analysis of anaplastic lymphoma kinase expression in deep soft tissue calcifying fibrous pseudotumor: evidence of a late sclerosing stage of inflammatory myofibroblastic tumor?
    Sigel JE; Smith TA; Reith JD; Goldblum JR
    Ann Diagn Pathol; 2001 Feb; 5(1):10-4. PubMed ID: 11172201
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudosarcomatous myofibroblastic proliferations of the bladder: a clinicopathologic study of 42 cases.
    Harik LR; Merino C; Coindre JM; Amin MB; Pedeutour F; Weiss SW
    Am J Surg Pathol; 2006 Jul; 30(7):787-94. PubMed ID: 16819319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of residual tumor cells in bladder biopsy specimens: pitfalls in the interpretation of cytokeratin stains.
    Tamas EF; Epstein JI
    Am J Surg Pathol; 2007 Mar; 31(3):390-7. PubMed ID: 17325480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primitive myxoid mesenchymal tumor of infancy: a clinicopathologic report of 6 cases.
    Alaggio R; Ninfo V; Rosolen A; Coffin CM
    Am J Surg Pathol; 2006 Mar; 30(3):388-94. PubMed ID: 16538060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paratesticular fibrous pseudotumor: a morphologic and immunohistochemical study of 13 cases.
    Miyamoto H; Montgomery EA; Epstein JI
    Am J Surg Pathol; 2010 Apr; 34(4):569-74. PubMed ID: 20216379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The immunohistochemical profile of oral inflammatory myofibroblastic tumors.
    Salgueiredo-Giudice F; Fornias-Sperandio F; Martins-Pereira E; da Costa dal Vechio AM; de Sousa SC; dos Santos-Pinto-Junior D
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Jun; 111(6):749-56. PubMed ID: 21459633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-grade myofibroblastic sarcoma: analysis of 18 cases in the spectrum of myofibroblastic tumors.
    Mentzel T; Dry S; Katenkamp D; Fletcher CD
    Am J Surg Pathol; 1998 Oct; 22(10):1228-38. PubMed ID: 9777985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-grade sarcomas with CD34-positive fibroblasts and low-grade myofibroblastic sarcomas.
    Fisher C
    Ultrastruct Pathol; 2004; 28(5-6):291-305. PubMed ID: 15764578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myofibroblastic sarcomas: a clinicopathological study of 20 cases.
    Meng GZ; Zhang HY; Bu H; Zhang XL; Pang ZG; Ke Q; Liu X; Yang G
    Chin Med J (Engl); 2007 Mar; 120(5):363-9. PubMed ID: 17376304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammatory myofibroblastic tumor of the lung in children: anaplastic lymphoma kinase (ALK) expression and clinico-pathological correlation.
    Siminovich M; Galluzzo L; López J; Lubieniecki F; de Dávila MT
    Pediatr Dev Pathol; 2012; 15(3):179-86. PubMed ID: 22280150
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular characterization of inflammatory myofibroblastic tumors with frequent ALK and ROS1 gene fusions and rare novel RET rearrangement.
    Antonescu CR; Suurmeijer AJ; Zhang L; Sung YS; Jungbluth AA; Travis WD; Al-Ahmadie H; Fletcher CD; Alaggio R
    Am J Surg Pathol; 2015 Jul; 39(7):957-67. PubMed ID: 25723109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation.
    Miettinen MM; Sarlomo-Rikala M; Kovatich AJ; Lasota J
    Mod Pathol; 1999 Aug; 12(8):756-62. PubMed ID: 10463476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors.
    Griffin CA; Hawkins AL; Dvorak C; Henkle C; Ellingham T; Perlman EJ
    Cancer Res; 1999 Jun; 59(12):2776-80. PubMed ID: 10383129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-grade myofibroblastic sarcoma of the levator scapulae muscle: a case report and literature review.
    Yonezawa H; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Langit MB; Kimura H; Shimozaki S; Kato T; Morinaga S; Araki Y; Asano Y; Ikeda H; Nojima T; Tsuchiya H
    BMC Musculoskelet Disord; 2020 Dec; 21(1):836. PubMed ID: 33302922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
    Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
    Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of anaplastic lymphoma kinase in soft tissue tumors: an immunohistochemical and molecular study of 249 cases.
    Li XQ; Hisaoka M; Shi DR; Zhu XZ; Hashimoto H
    Hum Pathol; 2004 Jun; 35(6):711-21. PubMed ID: 15188137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adult-type fibrosarcoma: A reevaluation of 163 putative cases diagnosed at a single institution over a 48-year period.
    Bahrami A; Folpe AL
    Am J Surg Pathol; 2010 Oct; 34(10):1504-13. PubMed ID: 20829680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dedifferentiated liposarcoma with inflammatory myofibroblastic tumor-like features.
    Lucas DR; Shukla A; Thomas DG; Patel RM; Kubat AJ; McHugh JB
    Am J Surg Pathol; 2010 Jun; 34(6):844-51. PubMed ID: 20431481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 56.